WEI-CHIH LIAOChen, Chih-TaChih-TaChenTsai, You-ShuYou-ShuTsaiWang, Xin-YaXin-YaWangChang, Yen-TzuYen-TzuChangWu, Ming-ShiangMing-ShiangWuLU-PING CHOW2023-10-032023-10-032023-06-061471-2407https://scholars.lib.ntu.edu.tw/handle/123456789/635920Cancer cachexia, occurring in ~ 80% pancreatic cancer (PC) patients overall, is a paraneoplastic syndrome mediated by cancer-induced systemic inflammation and characterized by weight loss and skeletal muscle wasting. Identifying clinically relevant PC-derived pro-inflammatory factors with cachexigenic potential may provide novel insights and therapeutic strategies.enBiomarker; Cachexia; Muscle atrophy; Pancreatic cancer; S100A8; S100A9S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexiajournal article10.1186/s12885-023-11009-8372805162-s2.0-85161064377https://api.elsevier.com/content/abstract/scopus_id/85161064377